Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 10 Similar Profiles
HIV
Medicine & Life Sciences
Mortality
Medicine & Life Sciences
Coronary Disease
Medicine & Life Sciences
CD4 Lymphocyte Count
Medicine & Life Sciences
Blood Pressure
Medicine & Life Sciences
HIV Infections
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Cardiovascular Diseases
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1999 2024
Extended follow-up of randomized participants in the INSIGHT START trial
NIH Nat'l Inst of Allergy & Infect Dis
5/17/19 → 4/30/24
Project: Research project
MASTER: RFP S18-107 Expert Emergency Clinical Research Response
Leidos Biomedical Research, Inc.
10/5/18 → 6/30/23
Project: Research project
Emergencies
Research
Biomarkers
HIV
PREVAIL VI: Identification of Host Genetic Factors Under
Leidos Biomedical Research, Inc.
3/1/18 → 8/31/19
Project: Research project
Ebola Hemorrhagic Fever
Viral RNA
Humoral Immunity
Mortality
Research Output 1973 2019
1
Citation
(Scopus)
A longitudinal study of Ebola sequelae in Liberia
PREVAIL III Study Group, Mar 7 2019, In : New England Journal of Medicine. 380, 10, p. 924-934 11 p.Research output: Contribution to journal › Article
Liberia
Longitudinal Studies
Survivors
Uveitis
Ebolavirus
1
Citation
(Scopus)
Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: A post hoc analysis of the commander hf trial
Greenberg, B., Neaton, J., Anker, S. D., Byra, W. M., Cleland, J. G. F., Deng, H., Fu, M., La Police, D. A., Lam, C. S. P., Mehra, M. R., Nessel, C. C., Spiro, T. E., Van Veldhuisen, D. J., Vanden Boom, C. M. & Zannad, F., Jan 1 2019, In : JAMA cardiology.Research output: Contribution to journal › Article
Coronary Sinus
Coronary Disease
Heart Failure
Sudden Death
Coronary Artery Disease
Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program
Shavadia, J. S., Sharma, A., Gu, X., Neaton, J., DeLeve, L., Holmes, D., Home, P., Eckel, R. H., Watkins, P. B. & Granger, C. B., Jan 1 2019, In : Clinical Trials.Research output: Contribution to journal › Article
Clinical Trials Data Monitoring Committees
Aspartate Aminotransferases
Alanine Transaminase
Liver
Chemical and Drug Induced Liver Injury
1
Citation
(Scopus)
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape
Phillips, P. P. J., Mitnick, C. D., Neaton, J., Nahid, P., Lienhardt, C. & Nunn, A. J., Mar 1 2019, In : PLoS medicine. 16, 3, p. e1002767Research output: Contribution to journal › Article
Open Access
Tuberculosis
Clinical Trials
Therapeutics
Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3: Findings From the Strategic Timing of AntiRetroviral Therapy (START) Trial
INSIGHT START Study Group, May 1 2019, In : Journal of acquired immune deficiency syndromes (1999). 81, 1, p. 10-17 8 p.Research output: Contribution to journal › Article
CD4 Lymphocyte Count
HIV
Odds Ratio
RNA
Cell Count